StockData
ICON PLC logo

ICON PLC (ICLR) company profile

ICLRNasdaqServices-Commercial Physical & Biological Research
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 20-F on May 27, 2026Score 7/30
$195.02+3.62 (+1.89%)

Close on Nov 17, 2026Market cap $14.93BP/E 33.6Yield –

About ICON

Services-Commercial Physical & Biological Research, SIC 8731

ICON public limited company is a contract research organization that provides outsourced development, commercialization, and consulting services to the pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company supports all phases of the clinical development process, from compound selection through Phase I to IV clinical studies, post-approval research, and market access. Its core service offerings encompass clinical development, functional service partnerships, decentralized clinical trial solutions, and specialized laboratory testing, including bio-analytical, biomarker, vaccine, and central laboratory services.

The company operates globally with approximately 40,100 employees across 97 locations in 55 countries. Its dedicated site network includes 21 owned or embedded clinical sites across the United States, the United Kingdom, and Spain. ICON maintains its principal executive office and corporate headquarters in Dublin, Ireland.

Summary of the business section of ICON's latest annual report, written by StockData.

Company profile

Company

Legal name
ICON PLC
Founded
1990
Headquarters
Dublin 18, L2
Address
South County Business Park, Leopardstown 00000
Phone
00 353 1 291 2000
Employees
40,100, Dec 31, 2025
Industry
Services-Commercial Physical & Biological Research
Auditor
Ernst & Young Chartered Accountants, Dublin, Ireland

Stock & identifiers

Ticker
ICLR
Exchange
Nasdaq
IPO date
Aug 7, 2003
Shares outstanding
77M, Dec 31, 2025
Filer category
Large accelerated filer
Stock splits
2-for-1, Aug 13, 2008; 2-for-1, Oct 24, 2006
SEC CIK
1060955
CUSIP
G4705A100
FIGI
BBG000CTSZQ6
Share class FIGI
BBG001SDCL35
EIN
98-1067160

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Barry Edward BalfeChief Executive Officer, Director9,291
Nigel Bernard John ClerkinChief Financial Officer7,171
Emer LyonsChief Accounting Officer1,217
Ciaran MurrayDirector7,000
Eugene Pacelli McCagueDirector3,811
Ronan Martin MurphyDirector8,852
John Dr ClimaxDirector293,553
Anne Clem WhitakerDirector958
Kevin Francis EganDirector–
Julie O'NeillDirector3,588
Linda GraisDirector6,819
Jeffrey Thomas ElliottDirector–
Stephen A. CutlerDirector79,278

Employees

Headcount reported in annual reports

Corporate history

Events identified from SEC filings

See a number that looks wrong?